BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

19 related articles for article (PubMed ID: 2549055)

  • 1. Biosynthesis of the endogenous cyclic adenosine monophosphate (AMP) antagonist, prostaglandylinositol cyclic phosphate (cyclic PIP), from prostaglandin E and activated inositol polyphosphate in rat liver plasma membranes.
    Wasner HK; Lessmann M; Conrad M; Amini H; Psarakis E; Mir-Mohammad-Sadegh A
    Acta Diabetol; 1996 Jul; 33(2):126-38. PubMed ID: 8870815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Independent down-regulation of EP2 and EP3 subtypes of the prostaglandin E2 receptors on U937 human monocytic cells.
    Zeng L; An S; Goetzl EJ
    Immunology; 1995 Dec; 86(4):620-8. PubMed ID: 8567030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of A2 purinoceptor-stimulated surfactant phospholipid secretion in primary cultures of rat type II pneumocytes.
    Griese M; Gobran LI; Rooney SA
    Lung; 1993; 171(2):75-86. PubMed ID: 8381193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indomethacin treatment causes loss of insulin action in rats: involvement of prostaglandins in the mechanism of insulin action.
    Wasner HK; Weber S; Partke HJ; Amini-Hadi-Kiashar H
    Acta Diabetol; 1994 Dec; 31(4):175-82. PubMed ID: 7888687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of protein kinase A fails to alter mast cell adenosine responsiveness.
    Marquardt DL; Walker LL
    Agents Actions; 1994 Nov; 43(1-2):7-12. PubMed ID: 7741046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desensitization of the epidermal adenylate cyclase system: agonists and phorbol esters desensitize by independent mechanisms.
    Iizuka H; Asano K; Ito F; Tamura T; Takahashi H; Tsutsui M
    Biochim Biophys Acta; 1991 Jun; 1093(1):95-101. PubMed ID: 1646651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of protein kinase A and protein kinase C in prostanoid IP receptor desensitization in NG108-15 cells.
    Krane A; Malkhandi J; Mercy L; Keen M
    Biochim Biophys Acta; 1994 Jun; 1206(2):203-7. PubMed ID: 7516185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual effects of protein kinase-C on receptor-stimulated cAMP accumulation in a human T-cell leukemia line.
    Nordstedt C; Kvanta A; Van der Ploeg I; Fredholm BB
    Eur J Pharmacol; 1989 Mar; 172(1):51-60. PubMed ID: 2540999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of protein kinase C inhibits ATP-induced [Ca2+]i elevation in rat osteoblastic cells: selective effects on P2Y and P2U signaling pathways.
    Gallinaro BJ; Reimer WJ; Dixon SJ
    J Cell Physiol; 1995 Mar; 162(3):305-14. PubMed ID: 7860638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase C activators and bradykinin selectively inhibit vasopressin-stimulated cAMP synthesis in MDCK cells.
    Friedlander G; Amiel C
    Biochim Biophys Acta; 1987 Jul; 929(3):311-7. PubMed ID: 3038198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of adenosine A2 and prostaglandin E1 receptor-mediated cAMP generation by prior exposure of Swiss 3T3 fibroblasts to Ca2+-mobilizing receptor agonists or phorbol ester. Activation of protein kinase C triggers increases in the receptor density in cell membranes.
    Murayama T; Nomura Y; Ui M
    J Biol Chem; 1989 Sep; 264(26):15186-91. PubMed ID: 2549055
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.